UBS109
UBS109, as a curcumin analogue, can promote the differentiation and mineralization of osteoblasts. UBS109 shows to regulate bone cell function by activating Smad and inhibiting NF-kB. UBS109 can be used in bone tissue engineering and osteoporosis research[1].
Product Specifications
CAS Number
[1258513-40-4]
UNSPSC
12352005
Target
NF-κB
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ubs109.html
Purity
99.20
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1/C(CN(C)C/C1=C\C2=NC=CC=C2)=C/C3=NC=CC=C3
Molecular Formula
C18H17N3O
Molecular Weight
291.35
References & Citations
[1]Yamaguchi M, et al. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition[J]. Integrative biology, 2012, 4 (8) : 905-913.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
134052 50 µg
STYK1 (Serine/threonine/tyrosine Kinase 1, Tyrosine-protein Kinase STYK1, Novel Oncogene with Kinase Domain, NOK, Protein PK-unique, SuRTK106)
Ask
View Details 
C2408-11E 100 µg
CD53 (Antigen MOX44 Identified by Monoclonal Antibody MRC OX44, Cell Surface Glycoprotein CD53, Leukocyte Surface Antigen CD53, MOX44, Tetraspanin 25, Tetraspanin-25, TSPAN 25, TSPAN25, TSPAN-25) discontinued
Ask
View Details